Consuming too much salt has long been recognized as a primary driver of high blood pressure, but a growing body of scientific literature suggests that the consequences of a high-sodium diet extend far beyond the cardiovascular system. Recent investigations indicate that excessive salt intake can actively interfere with neurological functions, casting a shadow over memory retention, complex thinking, and emotional well-being. While hypertension remains a formidable public health challenge globally, these emerging insights into the brain-disrupting potential of sodium make the search for protective strategies more urgent than ever.
Addressing this medical frontier, a team of researchers in Japan has identified a promising therapeutic candidate in LPC70, a specialized compound derived from soybeans. Earlier exploratory work demonstrated that this unique ingredient possessed the capacity to mitigate both high blood pressure and cognitive impairments associated with high-salt diets in laboratory mice. Building upon those initial observations, a new, deeper investigation led by Japanese scientists has shed light on the exact mechanisms at play, revealing that the soy compound intricately modulates chemical signaling pathways in both the kidneys and the brain.
How a Soy Compound May Counter the Effects of Excess Salt
At the core of the new research are prostaglandins, a group of powerful signaling molecules synthesized within the body from a fundamental fatty acid known as arachidonic acid, or AA. Operating in a manner similar to local hormones, these biochemical messengers are tasked with regulating a vast array of essential physiological functions across multiple organ systems.
Within the cardiovascular network, prostaglandins play a critical balancing act, maintaining healthy blood pressure by carefully orchestrating the constriction and dilation of blood vessels. Their responsibilities within the central nervous system, however, are significantly more complex. Depending entirely upon which specific receptors they bind to and activate, prostaglandins can trigger signals that either shield fragile nerve cells from harm or promote detrimental inflammatory processes that impair memory, cognitive processing, and emotional regulation.
LPC70 is a specialized formulation of soy lysolecithin characterized by a high concentration of lysophosphatidylcholine, where LPC accounts for over 70 percent of the total phospholipid content. Although preceding laboratory trials established that LPC70 could alleviate salt-induced hypertension and cognitive deficits, the exact molecular pathways responsible for these protective benefits remained largely elusive, particularly regarding how the compound influences prostaglandin signaling dynamics.
To bridge this critical knowledge gap, an investigative team spearheaded by Professor Akihiro Mouri and Dr. Hisayoshi Kubota, in close collaboration with Dr. Kazuhiro Kagotani, set out to map the precise biochemical alterations induced by LPC70 in mice subjected to a high-salt diet.
Dr. Kubota, serving as the study’s first author, was instrumental in executing the rigorous experimental design. He meticulously evaluated systemic blood pressure, tracked subtle behavioral shifts in the subjects, and quantified the molecular activity tied directly to prostaglandin pathways. His comprehensive analyses ultimately clarified how LPC70 generates organ-specific protective effects across the distinct biological systems implicated in salt-induced cardiovascular and cognitive deterioration.
The principal researchers behind the study hold academic appointments within the Department of Regulatory Science for Evaluation and Development of Pharmaceuticals and Devices at the Fujita Health University Graduate School of Medical Science, alongside affiliations with the International Center for Brain Science at Fujita Health University. Meanwhile, Dr. Kagotani contributes his expertise through his work with Tsuji Oil Mills Co., Ltd., in Japan, and the Tsuji Health and Beauty Science Laboratory at Mie University.
The findings resulting from this extensive collaboration were released online on May 14, 2026, and subsequently published in Volume 197 of the academic journal Neurochemistry International on July 1, 2026.
Reflecting on the origins of the investigation, Professor Mouri explained that the team’s primary objective was to unravel the systemic coordination of prostaglandin signaling managed by LPC70. He noted that the research grew organically out of an ongoing partnership with Tsuji Oil Mills Co., Ltd., an enterprise dedicated to the development of naturally derived functional food ingredients.
Soy Compound Improves Blood Pressure and Memory in Mice
As anticipated by the research team, mice maintained on a high-salt diet rapidly developed elevated blood pressure levels. However, detailed behavioral and physiological observations confirmed that the detrimental toll of excessive dietary sodium reached well beyond circulatory strain.
The experimental subjects also exhibited noticeable behavioral shifts, including a reduction in social interaction and an impaired ability to recognize familiar objects encountered previously, signaling clear deficits in recognition memory. Interestingly, general locomotor activity and baseline anxiety-like behaviors remained largely unaffected. This specific profile indicates that excessive sodium consumption selectively disrupts higher-order cognitive and social processes rather than causing generalized, indiscriminate neurological impairment throughout the organism.
When the researchers introduced LPC70 as a dietary supplement to the high-salt regimen, a striking transformation occurred. The treated mice experienced tangible improvements in blood pressure regulation and demonstrated superior performance during behavioral testing, displaying restored social interaction capabilities and normal object recognition memory.
Encouraged by these behavioral and systemic recoveries, the scientific team turned their attention inward to investigate the biochemical changes occurring within the kidneys and brains of the subjects.
Different Protective Effects in the Kidneys and Brain
Analysis of the renal tissue revealed that a high-salt diet significantly upregulated the expression of two key molecular components involved in prostaglandin synthesis and signaling: cyclooxygenase-2, commonly known as COX-2, and the PGE2 receptor subtype EP3. Both of these proteins are strongly implicated in driving the physiological mechanisms that lead to salt-induced hypertension.
When LPC70 was administered, it effectively suppressed these salt-driven elevations in the kidneys. This targeted downregulation suggests that the soy-derived compound helps normalize renal signaling pathways that otherwise become dysfunctional under high-sodium conditions, thereby supporting healthy blood pressure control.
Conversely, the evaluation of the prefrontal cortex—a vital brain region responsible for executive function, complex thinking, memory retention, and social behavior—revealed a distinct pattern of molecular response.
Excessive salt consumption led to a marked reduction in the expression of the PGD2 receptor DP1, a protein that normally facilitates protective, anti-inflammatory signaling pathways within the brain tissue. Remarkably, supplementation with LPC70 successfully restored the expression levels of this beneficial receptor without altering DP2, a separate receptor associated with potentially neurotoxic and damaging cellular signaling cascades.
This dichotomy is critically important because it demonstrates that LPC70 does not act as a blunt instrument that merely amplifies or suppresses all prostaglandin activity indiscriminately. Instead, the compound exerts a refined, selective influence that favors neuroprotective signaling pathways, providing a plausible mechanistic explanation for the observed preservation of memory and social function in the treated subjects.
A Surprising Change in Chemical Signaling
Beyond tracking specific receptors, the investigative team uncovered an unexpected biochemical shift involving arachidonic acid, the foundational fatty acid utilized by biological systems to manufacture prostaglandins.
Mice subjected to a high-salt diet characteristically displayed lower circulating levels of available arachidonic acid. Paradoxically, when these same high-salt subjects received the LPC70 supplement, the systemic levels of downstream prostaglandins derived from this fatty acid—including both PGE2 and PGD2—actually increased.
This seemingly contradictory biochemical outcome suggests that LPC70 may optimize the body’s metabolic efficiency, enabling it to utilize dwindling supplies of arachidonic acid more effectively for prostaglandin production even under the metabolic stress of a high-salt environment.
When viewed collectively, these findings paint a picture of a coordinated yet highly nuanced physiological response. In the renal system, LPC70 counteracts hypertension by dampening pathological signaling changes. In the central nervous system, it bolsters defenses by restoring protective anti-inflammatory pathways. The ultimate therapeutic footprint of the compound is thus determined by a delicate interplay between the specific organ involved and the targeted regulation of individual prostaglandin receptors.
Could Soy-Based Ingredients Help Protect Against Excess Salt?
The implications of these findings point toward the eventual development of LPC70 as a valuable functional food ingredient designed to mitigate some of the adverse physiological tolls associated with high sodium intake.
Its demonstrated ability to concurrently ameliorate hypertension and protect cognitive performance in animal models raises the encouraging prospect that similar nutritional strategies could eventually support cardiovascular and neurological health in human populations frequently exposed to sodium-rich diets.
Nevertheless, researchers emphasize that these conclusions are derived entirely from preclinical animal models, meaning that extensive clinical trials involving human participants will be required to confirm whether these protective benefits translate across species.
Concluding the implications of the work, Professor Mouri noted that the investigation successfully clarifies the precise role played by LPC70 in regulating prostaglandin signaling networks. He added that the study establishes a solid foundation for future clinical research and targeted dietary interventions aimed at curbing hypertension-related cognitive decline and fostering healthy aging on a global scale.
The research delivers a significantly clearer understanding of how a natural, soy-derived compound can alter the body’s physiological response to high-sodium loads, opening fresh avenues for nutritional science in the preservation of long-term health.
Support for this scientific endeavor was provided through competitive Grants-in-Aid for Scientific Research issued by the Japan Society for the Promotion of Science, alongside specialized funding from the Fujita Mind-Brain Research & Innovation Center for Drug Generation under Japan’s Peak Research Universities Program, and the Japan Science and Technology Agency FOREST Program. Additional financial and resource contributions were supplied by Tsuji Oil Mills Co., Ltd., the Education and Research Facility of Animal Models for Human Diseases at Fujita Health University, the Smoking Research Foundation, and the Takeda Science Foundation.
